To study the role of magnetic resonance imaging in the diagnosis of lung pathologies in children.

Relevance: 

According to UNICEF, respiratory diseases occupy the first place due to the mortality of children from 0 to 14 years old.

Also, according to the World Health Organization (WHO), more than 2 million children under the age of 5 die from respiratory tract diseases every year, which is about 15% of the total number of child deaths and has socio-medical significance.

Given the need for repeated studies in children with chronic lung diseases such as oncological diseases, asthma, cystic fibrosis, bronchial dysplasia and others, there is a need to use advanced diagnostic methods that would provide high information content and radiation safety for patients.

At the moment, the first-line studies for lung pathology in children are: radiography and computed tomography of the chest.

According to WHO data from recent epidemiological studies among people who were exposed to medical radiation in childhood, the risk of developing cancer may increase even at lower doses (in the range of 50-100 mSv), which highlights the importance of non-radiation examination of patients with chronic diseases and subjected to constant dynamic monitoring.

Children are more sensitive to the effects of radiation and have a longer life expectancy, during which possible changes occur as a result of exposure.

Thus, the study of the role of magnetic resonance imaging in the diagnosis of lung pathologies in children is an urgent task from the standpoint of both clinical medicine and scientific activity.